share_log

Market-Moving News for May 20th

Benzinga ·  May 20 08:37

PTCT: 27% | PTC Therapeutics Announces European Commission Returns Translarna Opinion to CHMP For Re-evaluation

NKGN: 81% | NKGen Biotech Announces Its Safety Review Committee Has Cleared Co.'s SNK01 To Progress Into Phase 2 Development In Alzheimer's Disease

DYN: 25% | Dyne Therapeutics Announced Clinical Data From Its Ongoing Phase 1/2 ACHIEVE Trial Of DYNE-101 In Myotonic Dystrophy Type 1 And Phase 1/2 DELIVER Trial Of DYNE-251 In Duchenne Muscular Dystrophy

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment